Pfizer drops India vaccine application after regulator seeks local trial

Sharing is Caring!

When asked to participate in the trial or lose 1.4 billion customers, they chose to lose the customers.

Most maintstream media is silent on this.

Pfizer has withdrawn an application for emergency-use authorization of its Covid-19 vaccine in India that it has developed with Germany’s BioNTech, the company told Reuters on Friday.

The U.S. company, which was the first drugmaker to apply for emergency use authorization of its Covid-19 vaccine in India, had a meeting with the country’s drugs regulator on Wednesday and the decision was made after that, the company said.

See also  Services PMI drops to 52.1, manufacturing contracts—stagflation and economic weakness loom.

“Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time,” it said in a statement to Reuters.

“Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future.”

https://www.cnbc.com/2021/02/05/pfizer-withdraws-application-for-emergency-use-of-its-covid-19-vaccine-in-india.html

See also  History repeats: From subprime mortgages to dot-coms, now an everything bubble. A WallStreetBets trader with $1M+ in losses seeks a partner with $1M+ in gains to offset and share savings.

https://www.thehindu.com/news/national/pfizer-withdraws-emergency-use-authorisation-application-for-its-covid-19-vaccine-in-india/article33757258.ece

h/t BFD